KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-Current Deferred Tax Liability: 2009-2018

Historic Non-Current Deferred Tax Liability for Vertex Pharmaceuticals (VRTX) over the last 8 years, with Sep 2018 value amounting to $9.4 million.

  • Vertex Pharmaceuticals' Non-Current Deferred Tax Liability fell 11.87% to $9.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $9.4 million, marking a year-over-year decrease of 11.87%. This contributed to the annual value of $6.3 million for FY2017, which is 95.27% down from last year.
  • As of Q3 2018, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability stood at $9.4 million, which was up 0.85% from $9.3 million recorded in Q2 2018.
  • In the past 5 years, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability registered a high of $136.6 million during Q2 2017, and its lowest value of $6.3 million during Q4 2017.
  • For the 3-year period, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability averaged around $75.4 million, with its median value being $112.3 million (2016).
  • In the last 5 years, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability skyrocketed by 643.78% in 2016 and then slumped by 95.27% in 2017.
  • Vertex Pharmaceuticals' Non-Current Deferred Tax Liability (Quarterly) stood at $15.0 million in 2014, then soared by 634.11% to $110.4 million in 2015, then increased by 21.39% to $134.1 million in 2016, then slumped by 95.27% to $6.3 million in 2017, then fell by 11.87% to $9.4 million in 2018.
  • Its Non-Current Deferred Tax Liability stands at $9.4 million for Q3 2018, versus $9.3 million for Q2 2018 and $9.6 million for Q1 2018.